TY - JOUR
T1 - Towards a sustainable one health approach to crimean-congo hemorrhagic fever prevention
T2 - Focus areas and gaps in knowledge
AU - Sorvillo, Teresa E.
AU - Rodriguez, Sergio E.
AU - Hudson, Peter
AU - Carey, Megan
AU - Rodriguez, Luis L.
AU - Spiropoulou, Christina F.
AU - Bird, Brian H.
AU - Spengler, Jessica R.
AU - Bente, Dennis A.
N1 - Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
PY - 2020/9
Y1 - 2020/9
N2 - Crimean-Congo hemorrhagic fever virus (CCHFV) infection is identified in the 2018 World Health Organization Research and Development Blueprint and the National Institute of Allergy and Infectious Diseases (NIH/NIAID) priority A list due to its high risk to public health and national security. Tick-borne CCHFV is widespread, found in Europe, Asia, Africa, the Middle East, and the Indian subcontinent. It circulates between ticks and several vertebrate hosts without causing overt disease, and thus can be present in areas without being noticed by the public. As a result, the potential for zoonotic spillover from ticks and animals to humans is high. In contrast to other emerging viruses, human-to-human transmission of CCHFV is typically limited; therefore, prevention of spillover events should be prioritized when considering countermeasures. Several factors in the transmission dynamics of CCHFV, including a complex transmission cycle that involves both ticks and vertebrate hosts, lend themselves to a One Health approach for the prevention and control of the disease that are often overlooked by current strategies. Here, we examine critical focus areas to help mitigate CCHFV spillover, including surveillance, risk assessment, and risk reduction strategies concentrated on humans, animals, and ticks; highlight gaps in knowledge; and discuss considerations for a more sustainable One Health approach to disease control.
AB - Crimean-Congo hemorrhagic fever virus (CCHFV) infection is identified in the 2018 World Health Organization Research and Development Blueprint and the National Institute of Allergy and Infectious Diseases (NIH/NIAID) priority A list due to its high risk to public health and national security. Tick-borne CCHFV is widespread, found in Europe, Asia, Africa, the Middle East, and the Indian subcontinent. It circulates between ticks and several vertebrate hosts without causing overt disease, and thus can be present in areas without being noticed by the public. As a result, the potential for zoonotic spillover from ticks and animals to humans is high. In contrast to other emerging viruses, human-to-human transmission of CCHFV is typically limited; therefore, prevention of spillover events should be prioritized when considering countermeasures. Several factors in the transmission dynamics of CCHFV, including a complex transmission cycle that involves both ticks and vertebrate hosts, lend themselves to a One Health approach for the prevention and control of the disease that are often overlooked by current strategies. Here, we examine critical focus areas to help mitigate CCHFV spillover, including surveillance, risk assessment, and risk reduction strategies concentrated on humans, animals, and ticks; highlight gaps in knowledge; and discuss considerations for a more sustainable One Health approach to disease control.
KW - Animal-human interface
KW - Crimean-Congo hemorrhagic fever
KW - Livestock
KW - One Health
KW - Outbreak response
KW - Risk reduction
KW - Spillover
KW - Surveillance
KW - Tick
KW - Tick-borne virus
UR - http://www.scopus.com/inward/record.url?scp=85091934443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091934443&partnerID=8YFLogxK
U2 - 10.3390/tropicalmed5030113
DO - 10.3390/tropicalmed5030113
M3 - Review article
C2 - 32645889
AN - SCOPUS:85091934443
SN - 2414-6366
VL - 5
JO - Tropical Medicine and Infectious Disease
JF - Tropical Medicine and Infectious Disease
IS - 3
M1 - 113
ER -